Form 8-K - Current report:
SEC Accession No. 0001104659-21-030145
Filing Date
2021-03-01
Accepted
2021-03-01 17:21:09
Documents
14
Period of Report
2021-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm218321d1_8k.htm   iXBRL 8-K 27531
2 EXHIBIT 99.1 tm218321d1_ex99-1.htm EX-99.1 259893
6 GRAPHIC tm218321d1_ex99-1img01.jpg GRAPHIC 3824
  Complete submission text file 0001104659-21-030145.txt   492780

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cyrx-20210301.xsd EX-101.SCH 3187
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyrx-20210301_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyrx-20210301_pre.xml EX-101.PRE 22711
7 EXTRACTED XBRL INSTANCE DOCUMENT tm218321d1_8k_htm.xml XML 3591
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34632 | Film No.: 21699454
SIC: 2834 Pharmaceutical Preparations